Hyperglycemia Accentuates Persistent "Functional Uncoupling" of Cerebral Microvascular Nitric Oxide and Superoxide Following Focal Ischemia/Reperfusion in Rats

Translational Stroke Research

Volumn 3, Issue 4, 2012, Pages 482-490

  Fabian, Roderic H ^a,b   Kent, Thomas A ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cerebral blood flow; Cerebral infarction; Hyperglycemia; Nitric oxide; Superoxide anion

Indexed keywords

3 NITROTYROSINE; FLUORESCENT DYE; NITRIC OXIDE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL FUNCTION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN EDEMA; BRAIN INFARCTION; BRAIN MICROCIRCULATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOTHELIUM CELL; HYPERGLYCEMIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 84869797378     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0210-9     Document Type: Article

References (45)

1. Pulsinelli W, Waldman S, Sigsbee B, Rawlinson D, Scherer P, Plum F. Experimental hyperglycemia and diabetes mellitus worsen stroke outcome. Trans Am Neurol Assoc. 1980; 105: 21-4.
2. Royter V, Gur AY, Bova I, Bornstein NM. Hyperglycemia and acute ischemic stroke. Isr Med Assoc J. 2004; 6(10): 607-9.
3. Bellolio MF, Gilmore RM, Stead LG. Insulin for glycaemic control in acute ischaemic stroke. Cochrane database system rev (Online). 2011; 9: CD005346.
4. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke J Cereb Circ. 2008; 39(2): 384-9.
5. Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR, Investigators G. Glucose regulation in acute stroke patients (GRASP) trial: a randomized pilot trial. Stroke J cereb circ. 2009; 40(12): 3804-9.
6. Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metabol. 2007; 27(3): 435-51.
7. Bruno A, Williams LS, Kent TA. How important is hyperglycemia during acute brain infarction? Neurologist. 2004; 10(4): 195-200.
8. Cipolla MJ, Huang Q, Sweet JG. Inhibition of protein kinase Cbeta reverses increased blood-brain barrier permeability during hyperglycemic stroke and prevents edema formation in vivo. Stroke J cereb circ. 2011; 42(11): 3252-7.
9. Elgebaly MM, Ogbi S, Li W, Mezzetti EM, Prakash R, Johnson MH, et al. Neurovascular injury in acute hyperglycemia and diabetes: a comparative analysis in experimental stroke. Transl stroke res. 2011; 2(3): 391-8.
10. Ergul A, Elgebaly MM, Middlemore ML, Li W, Elewa H, Switzer JA, et al. Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol. 2007; 7: 33.
11. Ergul A, Li W, Elgebaly MM, Bruno A, Fagan SC. Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature. Vasc Pharmacol. 2009; 51(1): 44-9.
12. Quast MJ, Wei J, Huang NC, Brunder DG, Sell SL, Gonzalez JM, et al. Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metabol. 1997; 17(5): 553-9.
13. Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009; 335(1): 165-89.
14. Keep RF, Andjelkovic AV, Stamatovic SM, Shakui P, Ennis SR. Ischemia-induced endothelial cell dysfunction. Acta Neurochir Suppl. 2005; 95: 399-402.
15. Arrick DM, Mayhan WG. Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic rats. Microcirculation (New York, NY: 1994). 2010; 17(6): 439-46.
16. Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med J British Diabet Assoc. 2005; 22(8): 999-1004.
17. Benarroch EE. Nitric oxide: a pleiotropic signal in the nervous system. Neurology. 2011; 77(16): 1568-76.
18. Lai EY, Wellstein A, Welch WJ, Wilcox CS. Superoxide modulates myogenic contractions of mouse afferent arterioles. Hypertension. 2011; 58(4): 650-6.
19. Manea A. NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell Tissue Res. 2010; 342(3): 325-39.
20. Luis SA, Roper D, Incani A, Poon K, Haqqani H, Walters DL. Non-pharmacological therapy for atrial fibrillation: managing the left atrial appendage. Cardiol Res Pract. 2012; 2012: 304626.
21. Förstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem. 2006; 387(12): 1521-33.
22. Terpolilli NA, Kim SW, Thal SC, Kataoka H, Zeisig V, Nitzsche B et al. Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles. Circ Res. 2011; 110: 727-738.
23. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A. 1998; 95(16): 9220-5.
24. Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem. 1998; 273(40): 25804-8.
25. Fabian RH, Perez-Polo JR, Kent TA. Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia. Am J Physiol Heart Circ Physiol. 2008; 295(4): H1809-14.
26. Hu W, Kharlamov A, Wang Y, Perez-Trepichio AD, Jones SC. Directed sampling for electrolyte analysis and water content of micro-punch samples shows large differences between normal and ischemic rat brain cortex. Brain Res. 2000; 868(2): 370-5.
27. Quast MJ, Huang NC, Hillman GR, Kent TA. The evolution of acute stroke recorded by multimodal magnetic resonance imaging. Magn Reson Imag. 1993; 11(4): 465-71.
28. Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007; 6(3): 258-68.
29. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke J cereb circ. 1989; 20(1): 84-91.
30. Gerzanich V, Ivanova S, Zhou H, Simard JM. Mislocalization of eNOS and upregulation of cerebral vascular Ca2+ channel activity in angiotensin-hypertension. Hypertension. 2003; 41: 1124-30.
31. Robinson KM, Janes MS, Pehar M, Monette JS, Ross MF, Hagen TM, et al. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci U S A. 2006; 103(41): 15038-43.
32. Zielonka J, Kalyanaraman B. Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med. 2010; 48(8): 983-1001.
33. Memezawa H, Minamisawa H, Smith ML, Siesjo BK. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res Exp Hirnforsch Exp Cerebr. 1992; 89(1): 67-78.
34. Slinker BK. The statistics of synergism. J Mol Cell Cardiol. 1998; 30(4): 723-31.
35. Huang A, Yang YM, Feher A, Bagi Z, Kaley G, Sun D. Exacerbation of endothelial dysfunction during the progression of diabetes: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol. 2012; 302(6): R674-81.
36. Sercombe R, Vicaut E, Oudart N, Sercombe C, Girard P. Acetylcholine-induced relaxation of rabbit basilar artery in vitro is rapidly reduced by reactive oxygen species in acute hyperglycemia: role of NADPH oxidase. J Cardiovasc Pharmacol. 2004; 44(4): 507-16.
37. Yamagishi S, Matsui T. Nitric oxide, a Janus-faced therapeutic target for diabetic microangiopathy-friend or foe? Pharmacol Res Off J Italian Pharmacol Soc. 2011; 64(3): 187-94.
38. Castro L, Demicheli V, Tortora V, Radi R. Mitochondrial protein tyrosine nitration. Free Radic Res. 2011; 45(1): 37-52.
39. Won SJ, Tang XN, Suh SW, Yenari MA, Swanson RA. Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by increasing superoxide production. Ann Neurol. 2011; 70(4): 583-90.
40. Quast MJ, Wei J, Huang NC. Nitric oxide synthase inhibitor NG-nitro-l-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats. Brain Res. 1995; 677(2): 204-12.
41. Crabtree MJ, Channon KM. Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease. Nitr Oxide Biol Chem/Off J Nitr Oxide Soc. 2011; 25(2): 81-8.
42. Noguchi K, Hamadate N, Matsuzaki T, Sakanashi M, Nakasone J, Uchida T, et al. Increasing dihydrobiopterin causes dysfunction of endothelial nitric oxide synthase in rats in vivo. Am J Physiol Heart Circ Physiol. 2011; 301(3): H721-9.
43. Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T, et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Hear J. 2009; 30(9): 1142-50.
44. Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke J cereb circ. 1997; 28(6): 1283-8.
45. Tang LL, Zheng JS. Effects of tetrahydrobiopterin on cerebral infarction after transient focal ischemia in rats. Neurol Res. 2011; 33(10): 1064-7.